THE COMBINATION QUESTION
More ingredients.
Better evidence?
A guide to peptide stacks: what the names mean, what has actually been studied, and which questions remain open.
Compare the stacks ↓What is a peptide stack?
On this site, a stack means a listed combination of peptides or other ingredients. Each guide distinguishes the combination from research on its ingredients. A plausible mechanism, an animal result, and a demonstrated clinical benefit answer different questions.
Wolverine, GLOW, and KLOW are commercial naming conventions for overlapping combinations.[1] Names and ratios can vary; always check the actual formulation.
30 STACK PAGES
Explore a stack
Wolverine stack
BPC-157 + TB-500
What is the Wolverine stack? Examine BPC-157 with TB-500, the small human subgroup, animal combination research, safety, and unanswered dosing questions.
Read the evidence guideCJC-1295 + ipamorelin
CJC-1295 + Ipamorelin
Separate CJC-1295 and ipamorelin hormone findings from claims about their stack. Explore DAC, sleep, muscle, recovery, and combination safety.
Read the evidence guideGLOW stack
BPC-157 + TB-500 + GHK-Cu
Explore the GLOW stack of BPC-157, TB-500, and GHK-Cu. Compare skin claims with topical research and understand the limits of evidence for the blend.
Read the evidence guideKLOW stack
BPC-157 + TB-500 + GHK-Cu + KPV
What does KPV add to KLOW? Review the four-peptide stack, mouse intestinal-inflammation research, GLOW comparisons, and safety uncertainties.
Read the evidence guideTesamorelin + ipamorelin
Tesamorelin + Ipamorelin
Tesamorelin + ipamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideSemaglutide + cagrilintide / CagriSema
Semaglutide + Cagrilintide
Semaglutide + cagrilintide / CagriSema: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideSemax + Selank
Semax + Selank
Semax + Selank: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideSermorelin + ipamorelin
Sermorelin + Ipamorelin
Sermorelin + ipamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideRetatrutide + cagrilintide
Retatrutide + Cagrilintide
Retatrutide + cagrilintide: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideMOTS-c + SS-31
MOTS-c + SS-31
MOTS-c + SS-31: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideBPC-157 + KPV
BPC-157 + KPV
BPC-157 + KPV: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTesamorelin + CJC-1295 + ipamorelin
Tesamorelin + CJC-1295 + Ipamorelin
Tesamorelin + CJC-1295 + ipamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTirzepatide + cagrilintide
Tirzepatide + Cagrilintide
Tirzepatide + cagrilintide: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTesamorelin + AOD-9604
Tesamorelin + AOD-9604
Tesamorelin + AOD-9604: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTesamorelin + MOTS-c
Tesamorelin + MOTS-c
Tesamorelin + MOTS-c: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideAOD-9604 + MOTS-c
AOD-9604 + MOTS-c
AOD-9604 + MOTS-c: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideMOTS-c + NAD+
MOTS-c + NAD+
MOTS-c + NAD+: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideMOTS-c + SS-31 + NAD+
MOTS-c + SS-31 + NAD+
MOTS-c + SS-31 + NAD+: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideBPC-157 + TB-500 + KPV
BPC-157 + TB-500 + KPV
BPC-157 + TB-500 + KPV: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideBPC-157 + TB-500 + CJC-1295 + ipamorelin
BPC-157 + TB-500 + CJC-1295 + Ipamorelin
BPC-157 + TB-500 + CJC-1295 + ipamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideCJC-1295 + ipamorelin + GHK-Cu
CJC-1295 + Ipamorelin + GHK-Cu
CJC-1295 + ipamorelin + GHK-Cu: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideGHK-Cu + Epitalon
GHK-Cu + Epitalon
GHK-Cu + Epitalon: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideEpitalon + thymalin
Epitalon + Thymalin
Epitalon + thymalin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideDSIP + ipamorelin
DSIP + Ipamorelin
DSIP + ipamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guidePT-141 + oxytocin
PT-141 + Oxytocin
PT-141 + oxytocin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTirzepatide + tesamorelin
Tirzepatide + Tesamorelin
Tirzepatide + tesamorelin: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideRetatrutide + MOTS-c
Retatrutide + MOTS-c
Retatrutide + MOTS-c: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideRetatrutide + tirzepatide
Retatrutide + Tirzepatide
Retatrutide + tirzepatide: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideSemaglutide + B12
Semaglutide + B12
Semaglutide + B12: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideTirzepatide + B12
Tirzepatide + B12
Tirzepatide + B12: ingredient studies, complete-combination evidence gaps, dose, route and safety questions in the available research.
Read the evidence guideFour questions to ask of every stack
- Was the combination tested?A study of one ingredient is a different intervention.
- Does the formulation match?Match molecule, route, and product—not just the nickname.
- What outcome was measured?Hormone levels, pain, function, and tissue repair are separate endpoints.
- How much uncertainty remains?Read the population, limitations, and safety findings alongside the grade.
References
1 sources
- GLOW vs KLOW vs Wolverine Stack: Which One? — naming reference only (2026)Commercial description · Names and ingredients only